Somatogen (SMTG) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Somatogen (SMTG)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kirce Stojanovski who wrote (323)	11/19/1997 1:38:00 PM
From: Jeff Clegg	Read Replies (2) of 442

I would not waste any money on options at this point. I can not see any news that will forthcoming in the near term that would propel the stock enough to make any money on an option. Buying April options now would only result in losing the time premium on them. SMTG has a timeframe of anytime before June for signing a new corporate partner. They have also stated that they want to have Phase II completed prior to signing a new partner. I personally do not see Phase II (Part A) results being released before the end of January maybe the end of February. IMHO, It might be better to not even buy options on SMTG since it is so low priced as it is. Unless you can pick up the 7 1/2s for April or farther out for less than say 1/2, I would not risk it. The 10s are too far out of the money and the 5s do not leverage your money enough. The Forbes article was somewhat interesting. Over Christmas I plan on having a detailed conversation with some of my relatives concerning blood substitues. Several are doctors, including leaders of Emergency Room teams, so I hope to get their insight into these types of products. Regards, Jeff Kirce, did you see the volume on TUBY. Lots of buying going on.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next